Company Sibling Group Holdings Inc Other OTC

Equities

US8257821053

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Inactive Instrument

End-of-day quote Other OTC Other stock markets
- ^USD	-

2023	EV Electra LTD entered into a letter of intent to acquire DrazCanna, Inc. in a reverse merger transaction for $980 million.	CI
2023	Drazcanna, Inc. Announces CEO Changes	CI

DrazCanna, Inc. is engaged in providing cannabis products. The Company's products include flowers, edibles, extracts, topicals, and cannabidiol (CBD) products. The Company's extraction processes include CBD distillation for use in a line of topicals, edibles, oils and concentrates for consumer use. Its topical products provide opportunities for skin health and pain relief, such as anti-aging, skin disorder, pain relief and wound healing.

Managers	Title	Age	Since
Jihad Mohammad CEO	Chief Executive Officer	-	20/23/20
Hussein A. Anani CEO	Chief Executive Officer	-	01/21/01
Mouktar Makkouk DFI	Director of Finance/CFO	-	20/23/20

Members of the board	Title	Age	Since
Jihad Mohammad CEO	Chief Executive Officer	-	20/23/20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	9,949,644	9,378,304 ( 94.26 %)	0	94.26 %
Stock B	0	30	0	0

DrazCanna, Inc.

835 Mason Street Suite C-116

48124, Dearborn Heights

http://www.drazcanna.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+23.13%	46.93B
LONZA GROUP AG	+37.26%	39.08B
IQVIA HOLDINGS INC.	-8.73%	38.48B
ALNYLAM PHARMACEUTICALS, INC.	+28.09%	31.01B
CELLTRION, INC.	-12.26%	26.14B
ICON PUBLIC LIMITED COMPANY	+10.57%	25.88B
MEDPACE HOLDINGS, INC.	+32.23%	12.53B
BIO-TECHNE CORPORATION	-6.56%	11.36B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-12.56%	10.65B

Other Biotechnology & Medical Research